WW Stock Rallies 4% Pre-Market Today: What’s Powering The Rally?

• WeightWatchers partnered with Amazon Pharmacy to expand access to weight-loss medications.
   
• Members get real-time drug availability, automatic discounts, and fast delivery.

WW International, Inc. (WW), known as WeightWatchers, has partnered with Amazon Pharmacy to make prescription access to weight management drugs faster and more affordable. 

Simplifying Access To Weight-Loss Medications

The collaboration enables WeightWatchers Clinic members to view real-time drug availability, compare delivery options, and utilize Amazon Pharmacy for fulfillment, thereby ensuring greater speed and convenience. 

The partnership addresses growing demand for weight management medications by leveraging Amazon’s established pharmacy infrastructure. 

Following the announcement, WW International stock traded over 4% higher in Monday’s premarket. On Stocktwits, retail sentiment around the stock improved to ‘neutral’ from ‘bearish’ the previous day amid ‘high’ message volume levels. 

Reducing Costs And Logistical Hurdles

Through this integration, Amazon Pharmacy applies manufacturer-sponsored savings directly at checkout, removing the need for manual coupon entry or enrollment. 

Prime members receive free two-day delivery, with same-day service available in select areas. This approach aims to reduce costs and logistical hurdles, ensuring members can receive treatment without delays.

"At WeightWatchers, we're committed to making it simpler and faster to access the weight management medications they need, and our collaboration with Amazon Pharmacy does exactly that," - Jon Volkmann, COO, WeightWatchers. 

"By delivering speed, reliability, and convenience we’re helping members stay focused on their health goals, not on pharmacy logistics,” he said.

WeightWatchers’ clinical model combines medication with structured nutrition programs, behavior modification, and community-based support. A recent WeightWatchers Clinic study showed members lost an average of 21% of their body weight over 12 months, outperforming comparable telehealth programs and clinical trials.

WeightWatchers stock has lost 0.3% since its relisting on Nasdaq in July. 

Also See: Why Is GRAL Stock Rising Today?

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Share

·

Add us on